Infection of hepatocytes with 17-D vaccine-strain yellow fever virus induces a strong pro-inflammatory host response

Journal of General Virology

Volumn 92, Issue 10, 2011, Pages 2262-2271

  Woodson, Sara E ^a   Holbrook, Michael R ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; YELLOW FEVER VACCINE;

ARTICLE; CELL VIABILITY; CYTOKINE RELEASE; CYTOKINE RESPONSE; IMMUNE RESPONSE; INFLAMMATION; PRIORITY JOURNAL; YELLOW FEVER FLAVIVIRUS;

CELL LINE; CELL SURVIVAL; CYTOKINES; HEPATOCYTES; HUMANS; YELLOW FEVER VACCINE; YELLOW FEVER VIRUS;

YELLOW FEVER VIRUS;

EID: 80052917757     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.031617-0     Document Type: Article

References (45)

1. Anwar, A., Leong, K. M., Ng, M. L., Chu, J. J. & Garcia-Blanco, M. A. (2009). The polypyrimidine tract-binding protein is required for efficient dengue virus propagation and associates with the viral replication machinery. J Biol Chem 284, 17021-17029.
2. Bae, H.-G., Domingo, C., Tenorio, A., de Ory, F., Muñoz, J., Weber, P., Teuwen, D. E. & Niedrig, M. (2008). Immune response during adverse events after 17D-derived yellow fever vaccination in Europe. J Infect Dis 197, 1577-1584.
3. Belsher, J. L., Gay, P., Brinton, M., DellaValla, J., Ridenour, R., Lanciotti, R., Perelygin, A., Zaki, S., Paddock, C. & Querec, T. (2007). Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease. Vaccine 25, 8480-8485.
4. Cain, K. & Freathy, C. (2001). Liver toxicity and apoptosis: role of TGF-beta1, cytochrome c and the apoptosome. Toxicol Lett 120, 307-315.
5. Chan, R. C., Penney, D. J., Little, D., Carter, I. W., Roberts, J. A. & Rawlinson, W. D. (2001). Hepatitis and death following vaccination with 17D-204 yellow fever vaccine. Lancet 358, 121-122.
6. Doblas, A., Domingo, C., Bae, H. G., Bohórquez, C. L., de Ory, F., Niedrig, M., Mora, D., Carrasco, F. J. & Tenorio, A. (2006). Yellow fever vaccine-associated viscerotropic disease and death in Spain. J Clin Virol 36, 156-158.
7. Gardner, C. L. & Ryman, K. D. (2010). Yellow fever: a reemerging threat. Clin Lab Med 30, 237-260.
8. Gaucher, D., Therrien, R., Kettaf, N., Angermann, B. R., Boucher, G., Filali-Mouhim, A., Moser, J. M., Mehta, R. S., Drake, D. R., III & other authors (2008). Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med 205, 3119-3131.
9. Gerasimon, G. & Lowry, K. (2005). Rare case of fatal yellow fever vaccine-associated viscerotropic disease. South Med J 98, 653-656.
10. Hacker, U. T., Jelinek, T., Erhardt, S., Eigler, A., Hartmann, G., Nothdurft, H. D. & Endres, S. (1998). In vivo synthesis of tumor necrosis factor-alpha in healthy humans after live yellow fever vaccination. J Infect Dis 177, 774-778.
11. Hacker, U. T., Erhardt, S., Tschöp, K., Jelinek, T. & Endres, S. (2001). Influence of the IL-1Ra gene polymorphism on in vivo synthesis of IL-1Ra and IL-1b after live yellow fever vaccination. Clin Exp Immunol 125, 465-469.
12. Jenkins, G. (2008). The role of proteases in transforming growth factor-b activation. Int J Biochem Cell Biol 40, 1068-1078.
13. Khaiboullina, S. F., Rizvanov, A. A., Holbrook, M. R. & St Jeor, S. (2005). Yellow fever virus strains Asibi and 17D-204 infect human umbilical cord endothelial cells and induce novel changes in gene expression. Virology 342, 167-176.
14. Khalil, N. (1999). TGF-beta: from latent to active. Microbes Infect 1, 1255-1263.
15. Klotz, O. & Belt, T. H. (1930). The pathology of the liver in yellow fever. Am J Pathol 6, 663-688, 1.
16. Martinez, F. O., Sica, A., Mantovani, A. & Locati, M. (2008). Macrophage activation and polarization. Front Biosci 13, 453-461.
17. Martinez, F. O., Helming, L. & Gordon, S. (2009). Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27, 451-483.
18. Monath, T. P. (2010). Suspected yellow fever vaccine-associated viscerotropic adverse events (1973 and 1978), United States. Am J Trop Med Hyg 82, 919-921.
19. Monath, T. P. & Barrett, A. D. (2003). Pathogenesis and pathophysiology of yellow fever. Adv Virus Res 60, 343-395.
20. Monath, T. P., Ballinger, M. E., Miller, B. R. & Salaun, J. J. (1989). Detection of yellow fever viral RNA by nucleic acid hybridization and viral antigen by immunocytochemistry in fixed human liver. Am J Trop Med Hyg 40, 663-668.
21. Monath, T. P., Lee, C. K., Julander, J. G., Brown, A., Beasley, D. W., Watts, D. M., Hayman, E., Guertin, P., Makowiecki, J. & Crowell, J. (2010). Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activity. Vaccine 28, 3827-3840.
22. Preiss, S., Thompson, A., Chen, X., Rodgers, S., Markovska, V., Desmond, P., Visvanathan, K., Li, K., Locarnini, S. & Revill, P. (2008). Characterization of the innate immune signalling pathways in hepatocyte cell lines. J Viral Hepat 15, 888-900.
23. Quaresma, J. A., Barros, V. L., Pagliari, C., Fernandes, E. R., Guedes, F., Takakura, C. F., Andrade, H. F., Jr, Vasconcelos, P. F. & Duarte, M. I. (2006). Revisiting the liver in human yellow fever: virus-induced apoptosis in hepatocytes associated with TGF-b, TNF-a and NK cells activity. Virology 345, 22-30.
24. Quaresma, J. A., Barros, V. L., Pagliari, C., Fernandes, E. R., Andrade, H. F., Jr, Vasconcelos, P. F. & Duarte, M. I. (2007). Hepatocyte lesions and cellular immune response in yellow fever infection. Trans R Soc Trop Med Hyg 101, 161-168.
25. Querec, T., Bennouna, S., Alkan, S., Laouar, Y., Gorden, K., Flavell, R., Akira, S., Ahmed, R. & Pulendran, B. (2006). Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med 203, 413-424.
26. Raghupathy, R., Chaturvedi, U. C., Al-Sayer, H., Elbishbishi, E. A., Agarwal, R., Nagar, R., Kapoor, S., Misra, A., Mathur, A. & other authors (1998). Elevated levels of IL-8 in dengue hemorrhagic fever. J Med Virol 56, 280-285.
27. Reinhardt, B., Jaspert, R., Niedrig, M., Kostner, C. & L'age-Stehr, J. (1998). Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection. J Med Virol 56, 159-167.
28. Rice, C. M., Grakoui, A., Galler, R. & Chambers, T. J. (1989). Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation. New Biol 1, 285-296.
29. Rummel, C., Sachot, C., Poole, S. & Luheshi, G. N. (2006). Circulating interleukin-6 induces fever through a STAT3-linked activation of COX-2 in the brain. Am J Physiol Regul Integr Comp Physiol 291, R1316-R1326.
30. Santos, A. P., Matos, D. C., Bertho, A. L., Mendonça, S. C. & Marcovistz, R. (2008). Detection of Th1/Th2 cytokine signatures in yellow fever 17DD first-time vaccinees through ELISpot assay. Cytokine 42, 152-155.
31. Sbrana, E., Xiao, S. Y., Popov, V. L., Newman, P. C. & Tesh, R. B. (2006). Experimental yellow fever virus infection in the golden hamster (Mesocricetus auratus) III. Clinical laboratory values. Am J Trop Med Hyg 74, 1084-1089.
32. Silva, M. L., Espñrito-Santo, L. R., Martins, M. A., Silveira-Lemos, D., Peruhype-Magalhães, V., Caminha, R. C., de Andrade Maranhão-Filho, P., Auxiliadora-Martins, M., de Menezes Martins, R. & other authors (2010). Clinical and immunological insights on severe, adverse neurotropic and viscerotropic disease following 17D yellow fever vaccination. Clin Vaccine Immunol 17, 118-126.
33. Streetz, K. L., Wüstefeld, T., Klein, C., Manns, M. P. & Trautwein, C. (2001). Mediators of inflammation and acute phase response in the liver. Cell Mol Biol (Noisy-le-grand) 47, 661-673.
34. Suffredini, A. F., Fantuzzi, G., Badolato, R., Oppenheim, J. J. & O'Grady, N. P. (1999). New insights into the biology of the acute phase response. J Clin Immunol 19, 203-214.
35. Suksanpaisan, L., Cabrera-Hernandez, A. & Smith, D. R. (2007). Infection of human primary hepatocytes with dengue virus serotype 2. J Med Virol 79, 300-307.
36. Szabo, G., Mandrekar, P. & Dolganiuc, A. (2007). Innate immune response and hepatic inflammation. Semin Liver Dis 27, 339-350.
37. ter Meulen, J., Sakho, M., Koulemou, K., Magassouba, N., Bah, A., Preiser, W., Daffis, S., Klewitz, C., Bae, H. G. & other authors (2004). Activation of the cytokine network and unfavorable outcome in patients with yellow fever. J Infect Dis 190, 1821-1827.
38. Theiler, M. & Smith, H. H. (1937). The use of Yellow fever virus modified by in vitro cultivation for human immunization. J Exp Med 65, 787-800.
39. van der Beek, M. T., Visser, L. G. & de Maat, M. P. (2002). Yellow fever vaccination as a model to study the response to stimulation of the inflammation system. Vascul Pharmacol 39, 117-121.
40. Verschuur, M., van der Beek, M. T., Tak, H. S., Visser, L. G. & de Maat, M. P. (2004). Interindividual variation in the response by fibrinogen, C-reactive protein and interleukin-6 to yellow fever vaccination. Blood Coagul Fibrinolysis 15, 399-404.
41. Wheelock, E. F. & Sibley, W. A. (1965). Circulating virus, interferon and antibody after vaccination with the 17-D strain of Yellow fever virus. N Engl J Med 273, 194-198.
42. Whittembury, A., Ramirez, G., Hernández, H., Ropero, A. M., Waterman, S., Ticona, M., Brinton, M., Uchuya, J., Gershman, M. & Toledo, W. (2009). Viscerotropic disease following yellow fever vaccination in Peru. Vaccine 27, 5974-5981.
43. Woodson, S. E., Freiberg, A. N. & Holbrook, M. R. (2011). Differential cytokine responses from primary human Kupffer cells following infection with wild-type or vaccine strain yellow fever virus. Virology 412, 188-195.
44. World Health Organization (2006). Yellow fever statistics and information.
45. Zhou, Z., Wang, N., Woodson, S. E., Dong, Q., Wang, J., Liang, Y., Rijnbrand, R., Wei, L., Nichols, J. E. & Guo, J.-T. (2011). Antiviral activities of ISG20 in positive-strand RNA virus infections. Virology 409, 175-188.